Pharmacogenomic testing (PGx) provides clinically meaningful improvement in response and remission rates for difficult-to-treat depression patients over standard of care, according to a study … [Read more...]
EMERGING TESTS
Study Showing PGx Testing Improves Depression Outcomes, Key to Myriad’s Reimbursement Strategy
February 18, 2019
INDUSTRY TRENDS
Diagnostics Sector Saw Increased Investment, Exits in 2018
January 28, 2019
Life science and health care companies had a banner year in 2018, with a record-breaking year for venture capital investment, according to Silicon Valley Bank's Trends in Healthcare Investments and … [Read more...]
EMERGING TESTS
Sequencing Shows Promise in Care of Common Kidney Disease
January 22, 2019
Exome sequencing can yield a genetic diagnosis in almost 10 percent of patients with chronic kidney disease (CKD), according to a study published Jan. 10 in the New England Journal of Medicine. This … [Read more...]
EMERGING TESTS
Cytokines Could Predict Risk of Side Effects From Immunotherapy
January 14, 2019
Blood-based cytokine markers may help identify cancer patients at greatest risk of developing side effects from immunotherapy treatment, according to a pilot study published Oct. 31 in the British … [Read more...]
EMERGING TESTS
Polygenic Risk Score Predicts Drug Efficacy with Schizophrenia
December 31, 2018
A polygenic risk score (PRS) may be able to predict response to antipsychotic drug treatment in patients with their first episode of psychosis from schizophrenia, according to a study published Nov. 5 … [Read more...]
PRECISION MEDICINE
Panel Size Affects Accuracy of Tumor Mutational Burden Calculation
December 17, 2018
Panel size is a critical determinant of test performance and cutoff values for determining the tumor mutational burden (TMB) to guide treatment decisions with immunotherapies, according to a study … [Read more...]
GENETIC TESTING
Sequencing-Based Panel May Improve Evaluation of Thyroid Nodules
December 10, 2018
A genetic test panel can help patients avoid unnecessary diagnostic thyroid surgeries, according to a study published Nov. 8 in JAMA Oncology. More than six in 10 of patients with thyroid nodules of … [Read more...]
EMERGING TESTS
At-Home, Smartphone-Based Urine Testing Now a Clinical Reality
December 3, 2018
In what has been called the "era of the medical selfie," at-home, smartphone-based urine testing is now a reality. In a short timeframe, the U.S. Food and Drug Administration (FDA) cleared … [Read more...]
INFORMATICS
AI May Cut ‘Wrong Blood in Tube’ Errors
October 29, 2018
Machine learning-based multianalyte delta checks may be effective at identifying 'wrong blood in tube' (WBIT) errors, according to a proof-of-concept study published in the American Journal of … [Read more...]
INNOVATION
Liquid Biopsies Enable Pediatric Brain Cancer Monitoring
October 29, 2018
Liquid biopsies may enable physicians to monitor treatment effectiveness for children with brain cancer, enabling detection of progression earlier than MRI imaging, according to a small study … [Read more...]
